These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35283394)

  • 1. The Treatment of Systemic Sclerosis-related Pericarditis.
    Yoshimi R; Nakajima H
    Intern Med; 2022 Oct; 61(20):2997-2998. PubMed ID: 35283394
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful Treatment of Systemic Sclerosis-related Pericarditis with Mycophenolate Mofetil and Low-dose Prednisolone.
    Higashioka K; Migita R; Ota T; Uchino A; Niiro H
    Intern Med; 2022 Oct; 61(20):3125-3130. PubMed ID: 35283383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of constrictive chronic pericarditis with mycophenolate sodium in a patient with systemic sclerosis.
    Fernández-Codina A; Francisco-Pascual J; Fonollosa-Plà V
    Med Clin (Barc); 2017 Jun; 148(12):574-575. PubMed ID: 28283274
    [No Abstract]   [Full Text] [Related]  

  • 4. Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases.
    Morel N; Bonjour M; Le Guern V; Le Jeunne C; Mouthon L; Piette JC; Costedoat-Chalumeau N
    Lupus; 2015 Dec; 24(14):1479-85. PubMed ID: 26163661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Large doses of adrenal corticosteroids in the treatment of pericarditis associated with progressive systemic sclerosis].
    Chen SL; Gu YY; Su LD
    Zhonghua Nei Ke Za Zhi; 1986 Oct; 25(10):616-7, 638. PubMed ID: 3568847
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
    Tashkin DP; Roth MD; Clements PJ; Furst DE; Khanna D; Kleerup EC; Goldin J; Arriola E; Volkmann ER; Kafaja S; Silver R; Steen V; Strange C; Wise R; Wigley F; Mayes M; Riley DJ; Hussain S; Assassi S; Hsu VM; Patel B; Phillips K; Martinez F; Golden J; Connolly MK; Varga J; Dematte J; Hinchcliff ME; Fischer A; Swigris J; Meehan R; Theodore A; Simms R; Volkov S; Schraufnagel DE; Scholand MB; Frech T; Molitor JA; Highland K; Read CA; Fritzler MJ; Kim GHJ; Tseng CH; Elashoff RM;
    Lancet Respir Med; 2016 Sep; 4(9):708-719. PubMed ID: 27469583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pericardial tamponade and systemic sclerosis].
    Astigarraga B; Yebra M; Marazuela M; Lacoma F; Gea JC; Barrera A
    Rev Esp Cardiol; 1990 May; 43(5):356-8. PubMed ID: 2203123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upfront Combination Therapy With Rituximab and Mycophenolate Mofetil for Progressive Systemic Sclerosis.
    Rimar D; Rosner I; Slobodin G
    J Rheumatol; 2021 Feb; 48(2):304-305. PubMed ID: 33060315
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of mycophenolate mofetil for treatment of interstitial lung disease in systemic sclerosis].
    Schneider U; Siegert E; Gläser S; Krüger K; ; Krause A
    Z Rheumatol; 2021 Nov; 80(9):868-878. PubMed ID: 34545432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].
    Sicińska J; Rudnicka L
    Pol Merkur Lekarski; 2008 Aug; 25(146):192-5. PubMed ID: 18942346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of mycophenolate mofetil for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: Information from a Japanese hospital claims database.
    Funatogawa T; Narita Y; Tamura A; Mii K; Sugitani Y; Uchida T
    Mod Rheumatol; 2022 Jul; 32(4):755-760. PubMed ID: 34850080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug.
    Saketkoo LA; Espinoza LR
    Arch Intern Med; 2008 Aug; 168(15):1718-9. PubMed ID: 18695091
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effectiveness of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease.
    Gkiouras K; Grammatikopoulou MG; Simopoulou T; Daniil Z; Bogdanos DP
    Clin Rheumatol; 2021 Aug; 40(8):3379-3380. PubMed ID: 34213671
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis.
    Shenoy PD; Bavaliya M; Sashidharan S; Nalianda K; Sreenath S
    Arthritis Res Ther; 2016 Jun; 18(1):123. PubMed ID: 27255492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple eruptive dermatofibromas aggravated by mycophenolate mofetil and pirfenidone in a patient with systemic sclerosis.
    Wang R; Li G; Nong L; Wang M
    Rheumatology (Oxford); 2020 Dec; 59(12):4000-4001. PubMed ID: 32572469
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mycophenolate mofetil in the treatment of selected connective tissue diseases].
    Batko B; Krawiec P; Osieleniec J; Sułowicz W
    Przegl Lek; 2013; 70(9):724-9. PubMed ID: 24455833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis.
    Ma X; Tang R; Luo M; Zeng Z; Shi Y; Tang B; Xiao R
    Clin Rheumatol; 2021 Aug; 40(8):3185-3193. PubMed ID: 34080081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.
    Volkmann ER; Tashkin DP
    Ann Am Thorac Soc; 2016 Nov; 13(11):2045-2056. PubMed ID: 27560196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericarditis in exacerbation of ulcerative colitis.
    Virovic Jukic L; Duvnjak M; Barsic N; Lerotic I; Tomasic V; Pavic T
    Acta Gastroenterol Belg; 2006; 69(4):390-2. PubMed ID: 17343082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.
    Volkmann ER; Tashkin DP; Li N; Roth MD; Khanna D; Hoffmann-Vold AM; Kim G; Goldin J; Clements PJ; Furst DE; Elashoff RM
    Arthritis Rheumatol; 2017 Jul; 69(7):1451-1460. PubMed ID: 28376288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.